Approval · Notice of Compliance 2942 · 1998
GEMZAR: Notice of Compliance 2942
Issued February 19, 1998
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2942
- Date
- February 19, 1998
- Company
- Eli Lilly Canada IncToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New indication: use in the treatment of pancreatic cancer
- Therapeutic class
- Antineoplastic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| GEMZAR | Not yet assigned | — |
Medicinal ingredients
- GEMCITABINE HYDROCHLORIDE 200 MG per VIAL
- GEMCITABINE HYDROCHLORIDE 1,000 MG per VIAL